Cargando…
The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples
To find new potentially therapeutic drugs against clear cell Renal Cell Carcinoma (ccRCC), within drugs currently prescribed for other diseases (drug repositioning), we previously searched for drugs which are expected to bring the gene expression of 500 + ccRCC samples from The Cancer Genome Atlas c...
Autores principales: | Koudijs, Karel K. M., Terwisscha van Scheltinga, Anton G. T., Böhringer, Stefan, Schimmel, Kirsten J. M., Guchelaar, Henk-Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385172/ https://www.ncbi.nlm.nih.gov/pubmed/30792476 http://dx.doi.org/10.1038/s41598-019-39891-y |
Ejemplares similares
-
Personalised drug repositioning for Clear Cell Renal Cell Carcinoma using gene expression
por: Koudijs, Karel K. M., et al.
Publicado: (2018) -
Validation of transcriptome signature reversion for drug repurposing in oncology
por: Koudijs, Karel K M, et al.
Publicado: (2022) -
Influence of batch effect correction methods on drug induced differential gene expression profiles
por: Zhou, Wei, et al.
Publicado: (2019) -
ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells
por: Kol, Arjan, et al.
Publicado: (2017) -
Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer
por: Ketzer, Sander, et al.
Publicado: (2017)